The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review.

Factors influencing scientific achievements of medical students in the Anatomy Research Group: An analysis from the Autonomous University of Nuevo León in Mexico

door
Factors influencing scientific achievements of medical students in the Anatomy Research Group: An analysis from the Autonomous University of Nuevo León in Mexico

Scientific analysis and scholar involvement are essential to the formation of physicians, but the variety of medical researchers has decreased over time. To implement corrective methods, the variables related to constructive analysis attitudes and productiveness amongst medical college students have to be recognized. The intention of this examine was to judge the variables related to college students or concerned in analysis. A validated questionnaire was utilized to the coed members of a longtime anatomy analysis group in a Mexican medical faculty with a six-year medical program. Information have been collected and analyzed.

A complete of 85.5% (n = 77/90) answered the survey with most respondents being second-year medical college students. An important element of conducting analysis was acknowledged to be contributing to new data (45.5%) and to the scientific group (42.9%) by most respondents. Greater than half point out a professor or a peer because the preliminary motivation to turn out to be concerned in analysis. Lack of time was the principle limitation (59.7%) to analysis involvement. Perceived advantages have been data and team-work expertise. Of these concerned, most (85.7%) wished to proceed collaborating in analysis as a complement to their medical work.

to focus on the principle attributes of Convergent Care Analysis that ratify it as a way of scientific analysis. Strategies: it’s a theoretical-reflective examine on Convergent Care Analysis’s theoretical-methodological assumptions. Improvement: Convergent Care Analysis is appropriate with the Social Constructionism paradigm. Convergent Care Analysis initiatives have two approaches: sensible and conceptual. The Convergent Care Analysis course of corpus incorporates 5 phases: conception; instrumentation; scrutiny; evaluation and theorizing.

Remaining Concerns: Convergent Care Analysis rigor encompasses the connection between analysis and care observe, and this corresponds to the convergence of those two dimensions. Attributable to its theoretical basis and standards of methodological rigor, Convergent Care Analysis is aligned with scientific analysis strategies. Professors and scholar colleagues have been discovered to play an necessary motivational and recruitment position for medical analysis. These efforts in flip will become mentor-mentee relationships. Early involvement in analysis as a scholar is anticipated to positively affect the probability of future physicians contribution and collaborating in analysis.

Small RNA analysis and the scientific repertoire: a story about biochemistry and genetics, crops and worms, improvement and illness

The invention of RNA interference in 1998 has made a long-lasting impression on organic analysis. Figuring out the regulatory position of small RNAs modified the modes of molecular organic inquiry in addition to biologists’ understanding of genetic regulation. This text examines the early years of small RNA biology’s success story. I question which elements needed to come collectively in order that small RNA analysis got here into life within the blink of a watch. I primarily take a look at scientific repertoires as facilitators of fast scientific change.

I present that for a brief time period, between the years 1998 and 2002, totally different mannequin organism communities, investigative methods, technological improvements, and analysis pursuits may very well be efficiently aligned to take small RNA analysis off the bottom. I talk about how the keystone discoveries have been located in particular experimental traditions and what methods have been employed to determine these discoveries as extra normal phenomena. Offering thus a practice-based strategy of fast scientific change, I ask learn how to relate the change in propositional bits of scientific data with modifications in scientific observe.

Factors influencing scientific achievements of medical students in the Anatomy Research Group: An analysis from the Autonomous University of Nuevo León in Mexico

Evaluating affected person views on collaborating in scientific analysis and medical trials for the remedy of spinal wire damage

A questionnaire was developed to judge sufferers’ perspective on analysis geared toward bettering features and overcoming issues related to spinal wire damage (SCI). The primary three sections have been based mostly on revealed and validated evaluation instruments. The ultimate part was developed to evaluate participant views on analysis for SCI. One thousand sufferers have been approached, of which 159 participated. Fifty-eight % of members have been happy with their ‘life as an entire’. Two elements may very well be generated that mirrored the variance within the information concerning members’ life with a SCI: “Psychosocial and bodily wellbeing” and “Impartial residing”.

The vast majority of members acknowledged they’d be concerned in analysis (86%) or medical trials (77%). Nonetheless, the probability of participation dropped when potential dangers of the analysis/trials have been defined. Which members can be prepared to take part in analysis couldn’t be predicted based mostly on the severity of their damage, their psychosocial and bodily wellbeing or their unbiased residing. Regardless of participant institution of a life with SCI, our information signifies that people try for enhancements in perform. Participant willingness to be included in analysis research is noteworthy and scientists and clinicians are inspired to contain extra sufferers in all elements of their analysis.

Recombinant Thermobifida Fusca Cutinase(C-6xHis)
CR10-1mg 1mg
EUR 2486
Description: Supplied as a 0.2 μm filtered solution of 10mM Tris-HCl,1mM 2-mercaptoethanol,2mM MnCl2,150mM NaCl,pH7.5.

Recombinant Thermobifida Fusca Cutinase(C-6xHis)
CR10-500ug 500ug
EUR 1755
Description: Supplied as a 0.2 μm filtered solution of 10mM Tris-HCl,1mM 2-mercaptoethanol,2mM MnCl2,150mM NaCl,pH7.5.

Recombinant Thermobifida Fusca Cutinase(C-6xHis)
CR10-50ug 50ug
EUR 496
Description: Supplied as a 0.2 μm filtered solution of 10mM Tris-HCl,1mM 2-mercaptoethanol,2mM MnCl2,150mM NaCl,pH7.5.

pET- NLS- Cas9- 6xHis
PVT10639 2 ug
EUR 301

pET-dCas9-VP64-6xHis
PVT17702 2 ug
EUR 300

pET-6xHis-(-30)GFP
PVT17881 2 ug
EUR 341

pLenti-CARM1 shRNA-2 Plasmid
PVTBAV03691-2 2 ug
EUR 356

pLenti-CTLA4 shRNA-2 Plasmid
PVTBAV05689-2 2 ug
EUR 356

pLenti-FOXM1 shRNA-2 Plasmid
PVTBAV08732-2 2 ug
EUR 356

pLenti-JUN shRNA-2 Plasmid
PVTBAV11741-2 2 ug
EUR 356

pLenti-LHX6 shRNA-2 Plasmid
PVTBAV12881-2 2 ug
EUR 356

pLenti-MAGEA3 shRNA-2 Plasmid
PVTBAV13661-2 2 ug
EUR 356

pLenti-RUNX3 shRNA-2 Plasmid
PVTBAV20583-2 2 ug
EUR 356

pLenti-Slc7a11 shRNA-2 Plasmid
PVTBAV21973-2 2 ug
EUR 356

pLenti-STAT3 shRNA-2 Plasmid
PVTBAV22921-2 2 ug
EUR 356

pLenti-XRCC5 shRNA-2 Plasmid
PVTBAV26238-2 2 ug
EUR 356

Mouse Anti-6xHIS Tag monoclonal antibody
CABT-BL8767 100ug
EUR 559

pDONR223-CD73 Plasmid
PVTB00480-2 2 ug
EUR 356

Multi Fusion-Tagged recombinant Protein 52-Kda containing 16-tags (T-7, HSV, C-myc, VSV-G, Glu-Glu, V5, e-tag, Flag, S-tag, HA, KT3, E2, Au1, Au5, 6xHis-tags) for ELISA/Western
MFPM52-C 100 ul
EUR 286

Plasmid Midi Kit I
K1314-2
EUR 262

Plasmid Midi Kit II
K1315-2
EUR 262

Plasmid ezFilter Mega3 Kit
K1320-2
EUR 343

Plasmid ezFilter Mega6 Kit
K1321-2
EUR 370

Plasmid ezFilter Mega10 Kit
K1322-2
EUR 452

pCR4-TOPO-RNF135 Plasmid
PVTB01189-2 2 ug
EUR 356

pGEM-Ltf(Q25R) Plasmid
PVTB50084-2 2 ug
EUR 356

Monoclonal Anti-Poly-His (6xhis) (His-tag) IgG
HISP14-M 100 ug
EUR 482

ToxOut? Endofree Plasmid Midi Kit
K1328-2
EUR 207

ToxOut? Endofree Plasmid Maxi Kit
K1330-2
EUR 234

ToxOut? Endofree Plasmid Mega3 Kit
K1332-2
EUR 316

ToxOut? Endofree Plasmid Mega6 Kit
K1333-2
EUR 370

ToxOut? Endofree Plasmid Mega10 Kit
K1334-2
EUR 425

pMD19-T-LEO1(E225G) Plasmid
PVTB01141-2 2 ug
EUR 356

Plasmid ezFilter Midi Kit I, Centrifuge
K1316-2
EUR 262

Plasmid ezFilter Midi Kit II, Centrifuge
K1317-2
EUR 262

Express Plasmid Midiprep Kit (25 min)
K1323-2
EUR 262

Express Plasmid Maxiprep Kit (25 min)
K1324-2
EUR 283

ToxOut? Endofree ezFilter Plasmid Midi Kit
K1329-2
EUR 207

ToxOut? Endofree ezfilter Plasmid Maxi Kit
K1331-2
EUR 234

ToxOut? Express Endofree Plasmid Midi Kit
K1335-2
EUR 234

ToxOut? Express Endofree Plasmid Maxi Kit
K1336-2
EUR 262

pCDH-EF1-CymR-T2A-Puro (plasmid)
QM200PA-2 10 ug
EUR 597

pCDH-EF1-CymR-T2A-Neo (plasmid)
QM400PA-2 10 ug
EUR 581

Phospholipid transfer Antibody
20-abx110096
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Monoclonal Anti-Poly-His (6xhis) (His-tag) antibody, ascites
HISP11-M 100 ul
EUR 482

Melanoma; Clone HMB45 (Concentrate)
A00019-C.2 0.2 ml
EUR 236

2-Propyl-β-D-glucuronide, 2 mg
0904-2 2 mg
EUR 162

HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate)
RA0108-C.1 0.1 ml
EUR 125

HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Concentrate)
RA0108-C.5 0.5 ml
EUR 300

Mitomycin C
2713-2
EUR 120

Goat Anti-Poly-His (6xhis) (His-tag) IgG, aff pure
HISP16-A 100 ug
EUR 408

Goat Anti-Poly-His (6xhis) (His-tag) IgG-FITC conjugate
HISP16-FITC 100 ul
EUR 347

Rabbit Anti-Poly-His (6xhis) (His-tag) IgG-IR700DX conjugate
HISP17-IR7 100 ul
EUR 408

IL-2 Interleukin-2 Human Recombinant Protein, His Tag
PROTP60568-2 Regular: 10ug
EUR 317
Description: Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 133 amino acids fragment (21-153) having a molecular weight of 20kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. _x000D_ The IL-2 His is purified by proprietary chromatographic techniques._x000D_

Rat cholest erolester transfer protein/lipid transfer protein ELISA kit
E02C0732-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Rat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse cholest erolester transfer protein/lipid transfer protein ELISA kit
E03C0732-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Mouse cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse cholest erolester transfer protein/lipid transfer protein ELISA kit
E03C0732-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Mouse cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse cholest erolester transfer protein/lipid transfer protein ELISA kit
E03C0732-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Mouse cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog cholest erolester transfer protein/lipid transfer protein ELISA kit
E08C0732-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Canine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog cholest erolester transfer protein/lipid transfer protein ELISA kit
E08C0732-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Canine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog cholest erolester transfer protein/lipid transfer protein ELISA kit
E08C0732-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Canine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat cholest erolester transfer protein/lipid transfer protein ELISA kit
E06C0732-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Goat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat cholest erolester transfer protein/lipid transfer protein ELISA kit
E06C0732-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Goat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat cholest erolester transfer protein/lipid transfer protein ELISA kit
E06C0732-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Goat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit cholest erolester transfer protein/lipid transfer protein ELISA kit
E04C0732-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Rabbit cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit cholest erolester transfer protein/lipid transfer protein ELISA kit
E04C0732-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Rabbit cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit cholest erolester transfer protein/lipid transfer protein ELISA kit
E04C0732-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Rabbit cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig cholest erolester transfer protein/lipid transfer protein ELISA kit
E07C0732-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Porcine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig cholest erolester transfer protein/lipid transfer protein ELISA kit
E07C0732-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Porcine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig cholest erolester transfer protein/lipid transfer protein ELISA kit
E07C0732-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Porcine cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat cholest erolester transfer protein/lipid transfer protein ELISA kit
E02C0732-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Rat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat cholest erolester transfer protein/lipid transfer protein ELISA kit
E02C0732-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Rat cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human cholest erolester transfer protein/lipid transfer protein ELISA kit
E01C0732-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Human cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human cholest erolester transfer protein/lipid transfer protein ELISA kit
E01C0732-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Human cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human cholest erolester transfer protein/lipid transfer protein ELISA kit
E01C0732-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Human cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey cholest erolester transfer protein/lipid transfer protein ELISA kit
E09C0732-192T 192 tests
EUR 1270
Description: A sandwich ELISA for quantitative measurement of Monkey cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey cholest erolester transfer protein/lipid transfer protein ELISA kit
E09C0732-48 1 plate of 48 wells
EUR 520
Description: A sandwich ELISA for quantitative measurement of Monkey cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey cholest erolester transfer protein/lipid transfer protein ELISA kit
E09C0732-96 1 plate of 96 wells
EUR 685
Description: A sandwich ELISA for quantitative measurement of Monkey cholest erolester transfer protein/lipid transfer protein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

BMP-2 Bone Morphogenetic Protein-2 Human Recombinant Protein, Monomer
PROTP12643-2 Regular: 20ug
EUR 317
Description: Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, Polypeptide chain containing 115 amino acids (283-396) and having a molecular mass of 13009 Dalton. ;The BMP-2 is purified by proprietary chromatographic techniques.

PG LIVER 2 EA*
59423-2 2 EA
EUR 192.24

Individual Reaction Mix 2
G065-2 200 reactions
EUR 167

Phospholipid transfer Antibody (Biotin)
20-abx105774
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Phospholipid transfer Antibody (FITC)
20-abx107192
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Phospholipid transfer Antibody (HRP)
20-abx108612
  • EUR 411.00
  • EUR 1845.00
  • EUR 599.00
  • EUR 182.00
  • EUR 300.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Phospholipid transfer Polyclonal Antibody
42297-100ul 100ul
EUR 333

pCMV-C-HA-Bcl-2 Plasmid
PVTB00307-2c 2 ug
EUR 356

Recombinant Human Relaxin-2 Protein
PROTP04090-2 25ug
EUR 317
Description: Relaxin-2 is a peptide hormone structurally related to insulin, which is expressed in the placenta, decidua, prostate, and in the ovary during pregnancy. Of the three known relaxin genes, Relaxin-2 is the only relaxin known to circulate in the blood. Relaxin-2 binds specifically to the LGR7 and LGR8 receptors, previously identified as an “orphan” G protein coupled receptors. Signaling by Relaxin-2 through its target receptors enhances the growth of pubic ligaments and ripening of the cervix during birth. Recombinant Relaxin-2 is a nonglycosylated 6.0 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 29 amino acid B-chain.

Recombinant Murine IL-2 Protein
PROTP04351-2 20ug
EUR 317
Description: IL-2 is a powerful immunoregulatory lymphokine produced by T-cells in response to antigenic or mitogenic stimulation. IL-2/IL-2R signaling is required for T-cell proliferation and other fundamental functions which are essential for the immune response. IL-2 stimulates growth and differentiation of B-cells, NK cells, lymphokine activated killer cells, monocytes, macrophages and oligodendrocytes. Recombinant murine IL-2 is a 17.2 kDa protein, containing 149 amino acid residues.

Recombinant Human PAI-2 Protein
PROTP05120-2 10ug
EUR 317
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein.

Recombinant Human MMP-2 Protein
PROTP08253-2 10ug
EUR 317
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-2 is a secreted collagenase with specificity toward Type IV, V, VII, and X collagens. Recombinant human MMP-2 is a 62.0 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (552 amino acids).

Recombinant Human BD-2 Protein
PROTO15263-2 20ug
EUR 317
Description: Defensins (alpha and beta) are cationic peptides with a broad spectrum of antimicrobial activity that comprise an important arm of the innate immune system. The α-defensins are distinguished from the β-defensins by the pairing of their three disulfide bonds. To date, six human β-defensins have been identified; BD-1, BD-2, BD-3, BD-4, BD-5 and BD-6. β-defensins are expressed on some leukocytes and at epithelial surfaces. In addition to their direct antimicrobial activities, they can act as chemoattractants towards immature dendritic cells and memory T cells. The β-defensin proteins are expressed as the C-terminal portion of precursors and are released by proteolytic cleavage of a signal sequence and in some cases, a propeptide sequence. β-defensins contain a six-cysteine motif that forms three intra-molecular disulfide bonds. Recombinant human BD-2 is a 4.3 kDa protein containing 41 amino acid residues.

Anti-ErbB 2/ERBB2 Antibody
A00010-2 100ug/vial
EUR 334

Anti-Bcl-2/BCL2 Antibody
A00040-2 100ug/vial
EUR 334

Anti-Angiopoietin-2/ANGPT2 Antibody
A00370-2 100ug/vial
EUR 334

Anti-Fascin 2/FSCN2 Antibody
A07840-2 100ug/vial
EUR 294

Bovine KIDNEY WHOLE 2 EA*
57120-2 2 EA
EUR 174.84

Anti-EIF4A1/2/3 Antibody
A03922-2 100ug/vial
EUR 334

Mouse FGF-2 Recombinant Protein
R00121-2 5ug/vial
EUR 259
Description: FGF basic (FGF2) is a multipotential fibroblast growth factor that stimulates and supports proliferation, migration and differentiation. Mouse FGF basic (FGF-2) Recombinant Protein is purified FGF basic (FGF-2) produced in yeast.

Empirical analysis on the Gateway Perception Mannequin (GBM) has flourished lately. The mannequin presents a dual-process account of how perspective change occurs in response to normative cues about scientific settlement. A plethora of correlational and experimental proof has emerged documenting the constructive direct and oblique results of speaking the scientific consensus on international warming. I evaluation current scholarship and argue that the subsequent era of analysis on the GBM ought to deal with higher justifying the inclusion of moderators on each a theoretical and empirical degree, explicitly manipulate motivations to course of the consensus message, mannequin how consensus cues function in aggressive info networks and take a look at the mannequin in subject settings utilizing causal chain experiments.

NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study

door
NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study

The paper addresses the problems of admissibility of human embryo analysis and the authorized safety to be acknowledged, in gentle of the rising significance that scientific analysis has been gaining within the medical and biomedical fields of embryonic stem cells for therapeutic functions. As for human embryo experimentation, notably on cryopreserved supernumerary embryos, European laws varies, for the reason that European Court docket has granted member States a large margin of appreciation.

Some nations, together with Italy, have strict laws defending embryos from the fertilisation stage, whereas others have taken permissive approaches, permitting experimentation till 14 days after fertilisation. Science, nevertheless, has proven that the 14-day restrict may be moved. The creator finds it mandatory to realize broad worldwide consensus and shared laws. Lawmakers, nevertheless, must stability respect for the precept of life, represented by the embryo, towards scientific wants, in an effort to devise sound laws safeguarding each apparently conflicting basic values.

The Analysis Challenge Grant (R01) is the oldest grant mechanism utilized by the Nationwide Institutes of Well being (NIH). Receiving an R01 award is usually taken as an indication of scientific success. We introduced normative information on a number of productiveness and impression metrics for a extra goal evaluation of funded grants’ scientific success.  All preliminary R01 grants awarded by NIH within the 12 months 2000 had been prospectively adopted and evaluated utilizing the numbers of publications and citations, in addition to the h-indices on the grant degree. We examined the variability, time traits, and relations amongst these metrics to raised perceive the funded tasks’ cumulative output and impression.

Introducing Key Components Relating to Entry to Private Information for Scientific Analysis within the Perspective of Growing Revolutionary Medicines

This text goals at opening discussions and selling future analysis about key components that must be taken under consideration when contemplating new methods to organise entry to non-public information for scientific analysis within the perspective of creating revolutionary medicines. It supplies an summary of those key components: the alternative ways of accessing information, the speculation of the important services, the Regulation on the Free Move of Non-personal Information, the Directive on Open Information and the re-use of public sector data, and the Basic Information Safety Regulation (GDPR) guidelines on accessing private information for scientific analysis.

Within the perspective of fostering analysis, selling revolutionary medicines, and having all of the uncooked information centralised in huge databases localised in Europe, we advise to additional examine the likelihood to search out acceptable and balanced options with full respect of basic rights, in addition to for personal life and information safety. These embrace utilizing open science platforms, pre-registering research, making certain reproducible analyses, utilizing high-powered research, making certain open entry to analysis supplies and merchandise, and conducting replication research.

Suicide analysis is vitally vital, yet-like psychology analysis extra broadly-faces methodological challenges. In recent times, researchers have raised considerations about customary practices in psychological analysis, considerations that apply to suicide analysis and lift questions on its robustness and validity. Within the current paper, we evaluate these considerations and the corresponding options put forth by the “open science” neighborhood.

We construct upon current guides, deal with particular obstacles confronted by suicide researchers, and supply a transparent set of beneficial practices for suicide researchers. Specifically, we contemplate challenges that suicide researchers could face in searching for to undertake “open science” practices (e.g., prioritizing massive samples) and recommend attainable methods that the sector could use in an effort to guarantee strong and clear analysis, regardless of these challenges.

NIH Funding, Research Productivity, and Scientific Impact: a 20-Year Study

Enhancing open and rigorous science: ten key future analysis alternatives associated to rigor, reproducibility, and transparency in scientific analysis

As a part of a coordinated effort to broaden analysis exercise round rigor, reproducibility, and transparency (RRT) throughout scientific disciplines, a crew of investigators on the Indiana College Faculty of Public Well being-Bloomington hosted a workshop in October 2019 with worldwide leaders to debate key alternatives for RRT analysis.

The workshop aimed to establish analysis priorities and alternatives associated to RRT.  Over two-days, workshop attendees gave displays and took part in three working teams: (1) Enhancing Training & Coaching in RRT, (2) Lowering Statistical Errors and Rising Analytic Transparency, and (3) Wanting Outward: Rising Truthfulness and Accuracy of Analysis Communications. Following small-group discussions, the working teams introduced their findings, and contributors mentioned the analysis alternatives recognized. The investigators compiled an inventory of analysis priorities, which had been circulated to all contributors for suggestions.

100bp DNA Marker
20-abx098052
  • EUR 272.00
  • EUR 189.00
  • 2.5 ml
  • 500 ul

Molecular Weight Marker
abx098957-15ul 15 ul
EUR 105

100bp DNA Marker
D1100-050 50㎍
EUR 165

100bp DNA Marker
D1100-250 5X50㎍
EUR 550

1Kb DNA Marker
D1101-050 50㎍
EUR 131

1Kb DNA Marker
D1101-250 5X50㎍
EUR 300

Oligodendrocyte Marker O1
MO15001 50 ug
EUR 331

Oligodendrocyte Marker O4
MO15002 50 ug
EUR 337

KP Marker Plus
KPM-1 12 Pen(s)
EUR 117

DL5000 DNA Marker
MD102-01 250 μl
EUR 107

DL5000 DNA Marker
MD102-02 500 μl
EUR 113

DL15000 DNA Marker
MD103-01 250 μl
EUR 109

DL15000 DNA Marker
MD103-02 500 μl
EUR 115

Myeloid Cell Marker (Macrophage / Granulocyte Marker); Clone BM-1 (Concentrate)
RA0400-C.1 0.1 ml
EUR 125

Myeloid Cell Marker (Macrophage / Granulocyte Marker); Clone BM-1 (Concentrate)
RA0400-C.5 0.5 ml
EUR 300

CMV-Luciferase (No marker)
LVP911a 1x107 IFU/ml x 200ul
EUR 349
Description: Pre-made lentivirus express firefly luciferase under CMV promoter (do not containing any antibiotic selection marker), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

EF1a-Luciferase (No marker)
LVP911b 1x107 IFU/ml x 200ul
EUR 349
Description: Pre-made lentivirus express firefly luciferase under EF1a promoter (do not containing any antibiotic selection marker), provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.

1Kb Plus DNA Marker
20-abx098051
  • EUR 300.00
  • EUR 203.00
  • 2.5 ml
  • 500 ul

Histiocytoma Marker(D11) Antibody
BNCA0348-250 250uL
EUR 383
Description: Primary antibody against Histiocytoma Marker(D11), APC conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNCA0719-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC719), APC conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNCA0740-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC02), APC conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNCA0754-250 250uL
EUR 383
Description: Primary antibody against Mitochondrial Marker(MTC754), APC conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNCA0894-250 250uL
EUR 383
Description: Primary antibody against Melanoma Marker(PNL2), APC conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNCAP0348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNCAP0348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNCAP0719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNCAP0719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNCAP0740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNCAP0740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNCAP0754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNCAP0754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNCAP0894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNCAP0894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC810348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF680R conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC810348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC810719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC810719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC810740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC810740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC810754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF680R conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC810754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF680R conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC810894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC810894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF680R conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC880348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF488A conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC880348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC880719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC880719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF488A conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNCB0348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), Biotin conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNCB0348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNCB0719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNCB0719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNCB0740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNCB0740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNCB0754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), Biotin conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNCB0754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), Biotin conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNCB0894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNCB0894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), Biotin conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC550348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF555 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC550348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF555 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC550719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF555 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC550719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF555 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC550740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF555 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC550740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF555 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC550754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF555 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC550754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF555 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC550894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF555 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC550894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF555 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC430348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF543 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC430348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF543 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC430719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF543 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC430719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF543 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC430740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF543 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC430740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF543 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC430754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF543 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC430754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF543 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC430894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF543 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC430894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF543 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC470348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF647 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC470348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC470719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC470719-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC719), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC470740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC470740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC470754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC470754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF647 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC470894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC470894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF647 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC880740-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC02), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC02) Antibody
BNC880740-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC02), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC880754-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC754), CF488A conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC754) Antibody
BNC880754-500 500uL
EUR 544
Description: Primary antibody against Mitochondrial Marker(MTC754), CF488A conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC880894-100 100uL
EUR 199
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL

Melanoma Marker(PNL2) Antibody
BNC880894-500 500uL
EUR 544
Description: Primary antibody against Melanoma Marker(PNL2), CF488A conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC940348-100 100uL
EUR 199
Description: Primary antibody against Histiocytoma Marker(D11), CF594 conjugate, Concentration: 0.1mg/mL

Histiocytoma Marker(D11) Antibody
BNC940348-500 500uL
EUR 544
Description: Primary antibody against Histiocytoma Marker(D11), CF594 conjugate, Concentration: 0.1mg/mL

Mitochondrial Marker(MTC719) Antibody
BNC940719-100 100uL
EUR 199
Description: Primary antibody against Mitochondrial Marker(MTC719), CF594 conjugate, Concentration: 0.1mg/mL

Members recognized the next precedence analysis questions: (1) Can RRT-focused statistics and mathematical modeling programs enhance statistics apply?; (2) Can specialised coaching in scientific writing enhance transparency?; (3) Does modality (e.g. nose to nose, on-line) have an effect on the efficacy RRT-related schooling?; (4) How can automated packages assist establish errors extra effectively?; 

What’s the prevalence and impression of errors in scientific publications (e.g., analytic inconsistencies, statistical errors, and different goal errors)?; (6) Do error prevention workflows cut back errors?; (7) How can we encourage post-publication error correction?; (8) How does ‘spin’ in analysis communication have an effect on stakeholder understanding and use of analysis proof?; (9) Do instruments to assist writing analysis studies enhance comprehensiveness and readability of analysis studies?; and (10) Is it attainable to inculcate scientific values and norms associated to truthful, rigorous, correct, and complete scientific reporting? Members recognized vital and comparatively unexplored questions associated to bettering RRT. This record could also be helpful to the scientific neighborhood and investigators searching for to advance meta-science (i.e. analysis on analysis).

Scientific HIV research in Africa and the Middle East: a socio-economic demographic analysis

door
Scientific HIV research in Africa and the Middle East: a socio-economic demographic analysis

Background: In Africa, HIV/AIDS analysis is concentrated in sure nations, notably South Africa. This distribution might not precisely replicate the illness prevalence or the true analysis efforts of nations. Aims: To establish HIV/AIDS analysis productiveness of nations in Africa and the Center East, in absolute phrases and adjusted for individuals dwelling with HIV, inhabitants dimension and financial growth. Strategies: We recognized all of the articles and opinions on HIV and AIDS within the Internet of Science Core Assortment through which African or Center Jap nations had participated. After figuring out the variety of paperwork produced by every nation, we adjusted the findings for the variety of individuals dwelling with HIV, variety of inhabitants, gross home product and gross nationwide revenue per capita. 

 African and Center Jap nations participated in 21.52% (n = 14 808) of all 68 808 paperwork analysed. East and Southern Africa produced 17.8% of all paperwork (n = 12 249), West and Central Africa accounted for under 3.34% (n = 2300), and the Center East and North Africa, 1.18% (n = 814). South Africa produced 40.94% (n = 6 063) of all publications. Solely two different African nations – Uganda (12.97%; n = 1 921) and Kenya (10.71%; n = 1 586) – produced greater than 10% of those publications. The indices used for adjusting analysis productiveness revealed the hassle and contribution of different nations. Conclusion: Our examine confirmed the main function of South Africa in driving HIV/AIDS analysis, but additionally highlighted the contribution of nations corresponding to Uganda, Malawi, Botswana, Zimbabwe and Mozambique.

In complete, 75 articles have been chosen. There was a rise within the variety of SRs on CBCT from 2014 onwards, as 83% of the SRs on this matter have been printed after 2013, and 72% between 2016 and up to now. Twenty SRs (27%) carried out meta-analysis. Solely 28% of the SRs supplied an in depth description of CBCT protocols. In response to SR proof, virtually all specialties of dentistry have superior concomitantly with the introduction of CBCT. Nearly all of SRs have been associated to medical purposes (degree 2 of efficacy), adopted by technical parameters (degree 1 of efficacy).

Just some CBCT fashions have been talked about within the SRs chosen. Over the course of twenty years, SRs associated to CBCT purposes for a broad vary of dental specialties have been printed, with the overwhelming majority of research at ranges 1 and a pair of of diagnostic efficacy. Not all fashions accessible in the marketplace have been scientifically validated. Always, one ought to stay cautious as such to not merely extrapolate in vitro outcomes to the medical setting. Additionally, contemplating the big variety of CBCT gadgets and protocols, reported outcomes shouldn’t be overstated or generalized, as outcomes typically confer with particular CBCT gadgets and protocols.

Bibliometric Evaluation of International Scientific Analysis on COVID-19

For the reason that outbreak of coronavirus illness 2019 (COVID-19), a lot of COVID-19-related studies have been printed in journals or submitted to preprint platforms. On this examine, we search the COVID-19-related literature formally printed and included within the Internet of Science (WOS) database or submitted to 4 preprint platforms: bioRxiv, medRxiv, Preprints, and SSRN. Utilizing knowledge on the variety of studies, creator establishment, nation, and analysis class, we analyze international tendencies in COVID-19 analysis, together with establishment distribution and analysis hotspots. The outcomes present that a lot of COVID-19-related studies have been produced; america has contributed probably the most printed literature, adopted by China.

America has additionally printed probably the most studies included within the WOS within the classes of non-pharmaceutical interventions, therapy, and vaccine-related studies, whereas China has printed probably the most literature within the classes of medical options and issues, virology and immunology, epidemiology, and detection and prognosis. Publication nations are concentrated in Asia, North America, and Europe, whereas South America and Africa have much less literature. In conclusion, many scientific analysis points associated to COVID-19 should be additional clarified and COVID-19 analysis urgently wants international cooperation.

Scientific HIV research in Africa and the Middle East: a socio-economic demographic analysis

Standardized Definitions for Analysis of Coronary heart Failure Therapies: Scientific Professional Panel From the Coronary heart Failure Collaboratory and Tutorial Analysis Consortium

The Coronary heart Failure Tutorial Analysis Consortium is a partnership between the Coronary heart Failure Collaboratory (HFC) and Tutorial Analysis Consortium (ARC), comprised of main coronary heart failure (HF) educational analysis investigators, sufferers, United States (US) Meals and Drug Administration representatives, and trade members from the US and Europe. A collection of conferences have been convened to ascertain definitions and key ideas for the analysis of HF therapies together with optimum medical and machine background remedy, medical trial design parts and statistical ideas, and examine endpoints.

miRNA Isolation Kit
FAMIK--001 Rxns: 100
EUR 332
Description: Contents of the kit:
  • Rxns:100Lysis
  • Buffer-10 ml
  • Acid-Phenol-10 ml
  • RNA Column and Collection Tube-100 sets
  • Wash Buffer-10 ml
  • Release Buffer-0.5 ml

miRNA Isolation Kit
FAMIK--002 Rxns: 50
EUR 223

Mitochondria Isolation Kit
AR0156 1 kit
EUR 106

miRNA Isolation Kit
FYG304-100P 100 Preps Ask for price

Endosome Isolation Kit
P528 - Ask for price

Microsome Isolation Kit
K249-50
EUR 528

Preadipocyte Isolation Kit
K583-5
EUR 533

MicroRNA Isolation Kit
KS341025 1 kit
EUR 256
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Cas9 Nickase: CMV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit
CASLV200PA-KIT 1 Kit
EUR 1132

Cas9 Nickase: CMV-hspCas9(D10A)-EF1-GFP SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit
CASLV205PA-KIT 1 Kit
EUR 1132

Cas9 Nickase: MSCV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit
CASLV220PA-KIT 1 Kit
EUR 1132

Cas9 Nickase: MSCV-hspCas9(D10A)-EF1-GFP SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit
CASLV225PA-KIT 1 Kit
EUR 1132

Total RNA Isolation Kit
P-9100 50 samples
EUR 347.25
Description: The best epigenetics products

Lipid Droplet Isolation Kit
MET-5011 50 preps
EUR 415
Description: Lipid droplets are lipid rich organelles found in the adipose tissue of eukaryotes. They function to regulate the hydrolysis and storage of neutral lipids and serve as storage for cholesterol and acyl-glycerols. Lipid droplets have also been associated with inflammatory responses, obesity, atherosclerosis, and cancer.

Cell Mitochondria Isolation Kit
abx090630-50100tests 50-100 tests
EUR 258

Tissue Mitochondria Isolation Kit
abx090631-50100assays 50-100 assays
EUR 258

Easy3-RNA Isolation Kit
FYG501-100P 100 Preps Ask for price

Easy3-RNA Isolation Kit
FYG501-500P 500 Preps Ask for price

Mitochondrial DNA Isolation Kit
K2117-50 50 assays
EUR 599

Genomic DNA Isolation Kit
K2118-50 50 assays
EUR 321

ExoPure? Isolation Kit   (Urine)
K1240-10
EUR 697

ExoPure? Isolation Kit   (Urine)
K1240-2
EUR 403

Apoptotic Cell Isolation Kit
K258-30
EUR 468

Yeast Mitochondria Isolation Kit
K259-50
EUR 419

Mitochondrial DNA Isolation Kit
K280-50
EUR 588

Genomic DNA Isolation Kit
K281-50
EUR 272

Yeast Nuclei Isolation Kit
K289-50
EUR 392

Lipopolysaccharide (LPS) Isolation Kit
K438-10
EUR 278

Apoptotic Cell Isolation Kit
55R-1349 30 units
EUR 729
Description: Apoptotic Cell Isolation Kit for use in the research laboratory

Mitochondrial DNA Isolation Kit
55R-1361 50 assays
EUR 825
Description: Mitochondrial DNA Isolation Kit for use in the research laboratory

Genomic DNA Isolation Kit
55R-1362 50 assays
EUR 385
Description: Genomic DNA Isolation Kit for use in the research laboratory

Cartilage RNA Isolation Kit
K2031010 1 kit
EUR 419
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation.

Saliva DNA Isolation Kit
K5011050 1 kit
EUR 256

Urine DNA Isolation Kit
K5011150 1 kit
EUR 256

Stool DNA Isolation Kit
K5011250 1 kit
EUR 256

Serum DNA Isolation Kit
K5018100 1 kit
EUR 360

Frit Kit
FRIT-KIT 1each
EUR 124
Description: Kit to create frits in capillaries. Includes formamide, Kasil-1, Kasil-1624 and a cleaving tool.

Circulating Nuleic Acid Isolation Kit
FACFK-050 50 preps
EUR 491

Circulating Nuleic Acid Isolation Kit
FACFK-100 100 preps
EUR 825

Total RNA Isolation Kit II
FATRS--001 100 preps
EUR 308

Total RNA Isolation Kit II
FATRS--050 50 preps
EUR 216

Rapid Bacteria RNA Isolation Kit
BS8625 50Preps
EUR 79.69

Rapid Blood RNA Isolation Kit
BT4182 10Preps
EUR 81.97

Rapid Blood RNA Isolation Kit
BT4183 50Preps
EUR 164.19

Rapid Blood RNA Isolation Kit
BT4184 250preps
EUR 506.75

FitAmp Gel DNA Isolation Kit
P-1007 100 Samples
EUR 270.4
Description: The best epigenetics products

FitAmp Urine DNA Isolation Kit
P-1017 100 Samples
EUR 395.1
Description: kits suitable for this type of research

ChromaFlash Chromatin Isolation & Shearing Kit
P-2023 100 Preperations
EUR 270.4
Description: kits suitable for this type of research

Total RNA Isolation Kit (Tissue)
P-9102 50 samples
EUR 347.25
Description: reagents widely cited

Total RNA Isolation Kit (Plant)
P-9104 50 samples
EUR 347.25
Description: kits suitable for this type of research

Rapid Plant RNA Isolation Kit
PT4191 50Preps
EUR 79.69

Easy3-Plant RNA Isolation Kit
FYG502-100P 100 Preps Ask for price

Easy3-Plant RNA Isolation Kit
FYG502-500P 500 Preps Ask for price

Easy3-Total NucleicAcid Isolation Kit
FYG504-100ML 100 ml Ask for price

Easy3-Total NucleicAcid Isolation Kit
FYG504-500ML 500 ml Ask for price

Exosome Isolation kit (for urine)
P120 - Ask for price

Exosome Isolation kit (for urine)
P120L - Ask for price

Exosome Isolation kit (for urine)
P120S - Ask for price

Detergent-Free Nuclei Isolation Kit
P524-2 - Ask for price

Detergent-Free Nuclei Isolation Kit
P524-20 - Ask for price

Detergent-Free Nuclei Isolation Kit
P524-80 - Ask for price

Lysosome Isolation Kit (20 tests)
P534 - Ask for price

Mouse Brain Microvessel Isolation Kit
P750-4 - Ask for price

Apoptotic DNA Ladder Isolation Kit
K2045-50 50 assays
EUR 502

Exo-Urine EV Isolation Kit
EXOU100A-1 2 x 5 reactions
EUR 551

ExoPure? Isolation Kit   (Cell Media)
K1237-10
EUR 664

ExoPure? Isolation Kit   (Cell Media)
K1237-2
EUR 392

ExoPure? Isolation Kit   (Serum, Plasma)
K1238-10
EUR 697

ExoPure? Isolation Kit   (Serum, Plasma)
K1238-2
EUR 392

ExoPure? Isolation Kit   (Bio Fluids)
K1241-10
EUR 697

ExoPure? Isolation Kit   (Bio Fluids)
K1241-2
EUR 403

Apoptotic DNA Ladder Isolation Kit
K170-50
EUR 468

EZExtract? Core Histone Isolation Kit
K234-100
EUR 262

Cell Surface Protein Isolation Kit
K295-10
EUR 501

Bacterial Genomic DNA Isolation Kit
K309-100
EUR 376

OrgFrontier? Plasma Membrane Isolation Kit
K414-10
EUR 566

Org Frontier? Chloroplast Isolation Kit
K468-10
EUR 555

Whole Blood DNA Isolation Kit
K528-100
EUR 376

XCF Exosomal DNA Isolation Kit
XCF200A-1 20 rxn
EUR 386

Column Packing Kit
PACK-KIT 1pack
EUR 1035
Description: Column packing kit for pressure cells. Includes: HPREG regulator, TBNG10 tubing, CAP-75 capillary, and STRB5X2 stir bar.

PSEUDOMONAS ISOLATION AGAR
P16-114-10kg 10 kg
EUR 1715

PSEUDOMONAS ISOLATION AGAR
P16-114-2kg 2kg
EUR 412

PSEUDOMONAS ISOLATION AGAR
P16-114-500g 500 g
EUR 148

PSEUDOMONAS ISOLATION BROTH
P16-115-10kg 10 kg Ask for price

PSEUDOMONAS ISOLATION BROTH
P16-115-2Kg 2 Kg Ask for price

PSEUDOMONAS ISOLATION BROTH
P16-115-500g 500 g Ask for price

PCR Mycoplasma Detection Kit
M034-Kit Kit
EUR 266

Cas9 Protein and T7 gRNA SmartNuclease Synthesis Kit
CAS400A-KIT 1 kit (10 rxn)
EUR 1110

Soil DNA Isolation Mini Kit (50prep)
FASOI-001 50 preps
EUR 158

Soil DNA Isolation Mini Kit (100prep)
FASOI-001-1 100 preps
EUR 201

Soil DNA Isolation Midi Kit (24prep)
FASOI-002 24 preps
EUR 216

Soil RNA Isolation Mini Kit (50prep)
FASRK-001 50 preps
EUR 150

Soil RNA Isolation Mini Kit (100prep)
FASRK-100 100 preps
EUR 187

Rapid Fungal Genomic DNA Isolation Kit
FT71415 50Preps
EUR 76.64

Rapid Bacteria Genomic DNA Isolation Kit
BS8225 50Preps
EUR 76.64

Methylamp Coupled DNA Isolation & Modification Kit
P-1002 40 Samples
EUR 395.1
Description: The best epigenetics products

This manuscript summarizes the professional panel discussions as consensus suggestions centered on populations and endpoint definitions; it isn’t exhaustive or restrictive, however designed to stimulate HF medical trial innovation. Murray Sidman’s (1960) Ways of Scientific Analysis: Evaluating Experimental Information in Psychology simply celebrated its sixtieth anniversary. It’s doubtless one of the vital influential books within the historical past of Conduct Evaluation. This evaluation outlines the rationales for, and particulars of, strategies for the investigation of the habits of particular person topics that Sidman offered. Lots of his observations and proposals are as well timed as ever, perhaps much more so, given the “reproducibility disaster” and certainly one of its main origins.

Reporting consciousness in coma: media framing of neuro-scientific research, hope, and the response of families with relatives in vegetative and minimally conscious states

door
Reporting consciousness in coma: media framing of neuro-scientific research, hope, and the response of families with relatives in vegetative and minimally conscious states

This paper examines the general public illustration of, and household responses to, scientific research into consciousness in coma-like states. We look at the publicity surrounding high-profile research utilizing purposeful Magnetic Resonance Imaging (fMRI) on ‘vegetative’ or ‘minimally aware’ sufferers and evaluate this with household views. Our findings present how, with a couple of notable exceptions, the analysis was offered as a tremendous breakthrough providing a possible ‘voice’ and selection for sufferers and hope and luxury for his or her households. We argue that such representations ignored key limitations, evoked unrealistic visions of restoration, and promoted very slim representations of household reactions.

The comparability between public representations of the science and responses from households with expertise of this situation highlights the complicated social/medical world into which neurotechnologies intervene, and factors to the absence of a variety of affected person/household views in public discourse. We conclude with recommendations for the way these selling the analysis, and the journalists reporting its implications, may act to make sure extra accountable protection and improve public debate.

First, we affirm earlier analysis in suggesting that e-cigarettes appeared to have triggered a breakdown of outdated public well being alliances. Second, we display that, amid issues about analysis high quality and amount, actors are guided by normative outlooks (and/or financial pursuits) of their assessments of proof. Third, we present that, regardless of describing e-cigarette debates as contentious and polarised, actors partaking in Scottish coverage debates exhibit a spectrum of views, with most interviewees occupying an unsure ‘center floor’ that’s attentive to new proof.

Fourth, we propose that the perceived divisiveness of e-cigarette debates is attributed to recurrent media simplifications and tensions arising from the behaviours of some actors with settled positions working to advertise explicit coverage responses (together with by strategically enrolling supportive proof). Fifth, we argue that the actions of those actors are doubtlessly defined by the prospect that e-cigarettes may usher in a brand new tobacco ‘coverage paradigm’. Lastly, we present how scientific authority is employed as a device inside these debates.

Chemosensory Programs in COVID-19: Evolution of Scientific Analysis

COVID-19 illness induced by coronavirus SARS-CoV-2 presents amongst its signs alterations of the chemosensory capabilities. Within the first research on the Chinese language inhabitants, this symptomatology was not notably related, and hyposmia and hypogeusia have been excluded from the signs to be evaluated to diagnose the illness. With the pandemic unfold of the sickness, there was an increase in reviews on chemosensory dysfunctions amongst sufferers. The primary information evaluation confirmed the presence of those problems primarily in paucisymptomatic and asymptomatic sufferers. The curiosity in chemosensory techniques due to this fact elevated significantly, as a result of the olfactory and gustatory signs could possibly be the important thing to cease the an infection unfold.
Moreover, the diploma of alert and a focus grew, contemplating that these kind of dysfunctions are prognostic signs of significant neurodegenerative illnesses. About 9 months have handed because the first anecdotal reviews on the involvement of the olfactory and gustatory techniques within the COVID-19 pathology. Because of this, a cautious evaluation of the literature was performed to grasp whether it is clearer which individuals current chemosensory signs and if these are associated to the severity of the illness. Moreover, we have now recognized which facets nonetheless stay to be clarified. This novel consequence may be defined with self-determination of students as an important determinant supporting scientific manufacturing that outclasses shrinking public analysis lab budgets and organizational deficiencies.
Throughout the early levels of the pandemic, analysis performed on hydroxychloroquine (HCQ) was chaotic and sparked a number of heated debates with respect to the scientific strategies used and the standard of data generated. Analysis on HCQ is used as a case research in each papers. The authors explored biomedical databases, peer-reviewed journals, pre-print servers, and media articles to establish related literature on HCQ and COVID-19, and examined philosophical views on medical analysis within the context of this pandemic and former world well being challenges.
Reporting consciousness in coma: media framing of neuro-scientific research, hope, and the response of families with relatives in vegetative and minimally conscious states

How self-determination of students outclasses shrinking public analysis lab budgets, supporting scientific manufacturing: a case research and R&D administration implications

The principle objective of this research is to research how reorganization of public analysis organizations and shrinking public analysis lab budgets have an effect on the evolution of analysis exercise and scientific productiveness. This research focuses on a case research of Nationwide Analysis Council of Italy (CNR), one among largest European public analysis organizations, to establish evolution of analysis actions and dynamics of scientific manufacturing from 2000 to 2019. The statistical evaluation means that, consistent with the origin of the CNR, scientific analysis focuses primarily on analysis fields of pure sciences, comparable to chemical, life and bodily sciences, with an growing position of scientific analysis in power, engineering and arithmetic.

Rabbit DNA (Double Stranded) ELISA kit
E04A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Rabbit DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit DNA (Double Stranded) ELISA kit
E04A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Rabbit DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit DNA (Double Stranded) ELISA kit
E04A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Rabbit DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse DNA (Double Stranded) ELISA kit
E03A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Mouse DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse DNA (Double Stranded) ELISA kit
E03A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Mouse DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse DNA (Double Stranded) ELISA kit
E03A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Mouse DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat DNA (Double Stranded) ELISA kit
E02A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Rat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat DNA (Double Stranded) ELISA kit
E02A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Rat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat DNA (Double Stranded) ELISA kit
E02A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Rat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat DNA (Double Stranded) ELISA kit
E06A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Goat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat DNA (Double Stranded) ELISA kit
E06A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Goat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat DNA (Double Stranded) ELISA kit
E06A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Goat DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig DNA (Double Stranded) ELISA kit
E07A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Porcine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig DNA (Double Stranded) ELISA kit
E07A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Porcine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig DNA (Double Stranded) ELISA kit
E07A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Porcine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog DNA (Double Stranded) ELISA kit
E08A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Canine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog DNA (Double Stranded) ELISA kit
E08A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Canine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog DNA (Double Stranded) ELISA kit
E08A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Canine DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey DNA (Double Stranded) ELISA kit
E09A0440-192T 192 tests
EUR 1270
Description: A competitive ELISA for quantitative measurement of Monkey DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey DNA (Double Stranded) ELISA kit
E09A0440-48 1 plate of 48 wells
EUR 520
Description: A competitive ELISA for quantitative measurement of Monkey DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey DNA (Double Stranded) ELISA kit
E09A0440-96 1 plate of 96 wells
EUR 685
Description: A competitive ELISA for quantitative measurement of Monkey DNA (Double Stranded) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC040945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC040945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC040946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC040946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC040958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC040958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF405S conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC470945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC470945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC470946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC470946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC470958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC470958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF647 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNCAP0945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNCAP0945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNCAP0946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNCAP0946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNCAP0958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNCAP0958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNCB0945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNCB0945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNCB0946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNCB0946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNCB0958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNCB0958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), Biotin conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC810945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC810945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC810946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC810946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC810958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC810958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF680R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC700945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC700945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC700946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC700946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC700958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC700958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF770 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC880945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC880945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC880946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC880946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC880958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC880958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF488A conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC610945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC610945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC610946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC610946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC610958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC610958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF660R conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC680945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC680945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC680946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC680946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC680958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC680958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF568 conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNCA0945-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), APC conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNCA0946-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), APC conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNCA0958-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), APC conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNUM0945-50 50uL
EUR 395
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), 1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNUM0946-50 50uL
EUR 395
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), 1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNUM0958-50 50uL
EUR 395
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), 1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC050945-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNC050945-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC050946-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNC050946-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC050958-100 100uL
EUR 199
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNC050958-500 500uL
EUR 544
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), CF405M conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNCP0945-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), PerCP conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNCP0946-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), PerCP conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNCP0958-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), PerCP conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNCR0945-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), RPE conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(AE-2) Antibody
BNCR0946-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(AE-2), RPE conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(DSD/958) Antibody
BNCR0958-250 250uL
EUR 383
Description: Primary antibody against Double Stranded DNA (dsDNA)(DSD/958), RPE conjugate, Concentration: 0.1mg/mL

Double Stranded DNA (dsDNA)(121-3) Antibody
BNUB0945-100 100uL
EUR 209
Description: Primary antibody against Double Stranded DNA (dsDNA)(121-3), Concentration: 0.2mg/mL

The research additionally exhibits a excessive depth of collaboration of the CNR inside worldwide analysis networks. A key discovering of this research is to indicate, for the primary time, that though unsure reforms and reductions of public funds, scientific productiveness is rising. The administration and analysis coverage implications of this research may be generalized to help an environment friendly organizational and managerial conduct, and better scientific productiveness of public analysis institutes in contexts of lowered public funding and market turbulence.